Patent · US Active

Method of treating Rett Syndrome (RTT) with ghrelin

US11154592B2 · kind B2 · utility

0Cited by
16References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 11, 2019
Grant dateOct 26, 2021
Priority date
Expiry dateJun 11, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating Rett Syndrome (RTT) comprising administering ghrelin to a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.